Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes: Efficacy of lipid-containing tear substitutes;Vergleichende studie zur therapie des trockenen auges bedingt durch lipidphasenstörungen mit lipidhaltigen tränenpräparaten: Zur wirksamkeit lipidhaltiger tränenpräparate

Klinische Monatsblatter fur Augenheilkunde

Volumn 223, Issue 12, 2006, Pages 974-983

  Dausch, D ^a,b,c,e   Lee, S ^a,b   Dausch, S ^a   Kim, J C ^b   Schwert, G ^c   Michelson, W ^d  

^a KLINIKUM ST MARIEN   (Germany)

^b Chung Ang University College of Medicine   (South Korea)

^c Augenärztliche Praxis ^*  (Germany)

^d Augenärztliche Praxis   (Germany)

^e Chung Ang University   (South Korea)

Author keywords

Carbomer; Dry eye; Eye gel; Eye spray; Keratoconjunctivitis sicca; Lipid layer; Non polar lipids; Phospholipids; Polar lipids; Triglycerides

Indexed keywords

AGENTS ACTING ON THE EYE; LIPID; LIPOSIC; TEARS AGAIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRY EYE; EYELID; FEMALE; HUMAN; LACRIMAL GLAND DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TEAR FILM; VISUAL ACUITY;

ADULT; AEROSOLS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GELS; HUMANS; LIPOSOMES; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PATIENT SATISFACTION; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; TRIGLYCERIDES; VISUAL ACUITY; XEROPHTHALMIA;

EID: 33846300666     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-927266     Document Type: Article

References (71)

1. Alster Y, Herlin L, Lazar M et al. Intraocular penetration of vancomycin eye drops after application to the medial canthus with closed lids. Br J Ophthalmol 2000; 84: 300-302
2. Berke A. Blinking frequency and the thickness of the lipid layer. In: Sullivan D et al (Hrsg). Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3. Kluwer Academic/Plenum Publishers, 2002: 513-516
3. Brandl H. Therapie des Trockenen Auges bei Störungen der Lipidphase. Wehrpharmazie und Wehrmedizin 2005; 29 (2): 55-56
4. Brewitt H, Höh H, Kaercher T et al. Das "Trockene Auge" - Diagnostik und Therapie. Z prakt Augenheilkd 1997; 18: 371-379
5. Brewitt H, Joost P. Klinische Studie zur Wirksamkeit eines nicht konservierten Tränenersatzmittels. Klin Monatsbl Augenheilkd 1991; 199: 160-164
6. Brewitt H, Rüfer F. Das trockene Auge. Klin Monatsbl Augenheilkd 2004; 221: R51-R70
7. Bron AJ, Daubas P, Siou-Mermet R et al. Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears. Eye 1998; 12 (Pt 5): 839-847
8. Bron AJ, Tiffany JM. The meibomian glands and tear film lipids. Structure, function, and control. In: Sullivan D et al (Hrsg). Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. New York: Plenum Press, 1998: 281-295
9. Bron AJ, Tiffany JM, Gouveia SM et al. Functional aspects of the tear film lipid layer. Exp Eye Res 2004; 78: 347-360
10. Brown SI, Dervichian DG. Hydrodynamics of blinking. In vitro study of the Interaktion of the superficial oily layer and the tears. Arch Ophthalmol 1969; 82: 541-547
11. Brown SI, Dervichian DG. The oils of the meibomian glands. Physical and surface characteristics. Arch Ophthalmol 1969; 82: 537-540
12. Chew CKS, Jansweijer C, Tiffany JM et al. An instrument for quantifying meibomian lipid on the lid margin: the Meibometer. Curr Eye Res 1993; 12: 247-254
13. Craig JP, Tomlinson A. Importance of the lipid layer in human tear stability and evaporation. Optom Vis Sci 1997; 74: 8-13
14. Diebold Y, Herreras JM, Callejo S et al. Carbomer- Versus Cellulose-Based Artificial-Tear Formulations: Morphologic and Toxicologic Effects on a Corneal Cell Line. Cornea 1998; 17: 433-440
15. Di Pascuale MA, Goto E, Tseng SCG. Sequential Changes of Lipid Tear Film after the Instillation of a Single Drop of a New Emulsion Eye Drop in Dry Eye Patients. Ophthalmology 2004; 111: 783-791
16. Dörfler HD. Grenzflächen und kolloid-disperse Systeme. Berlin, Heidelberg: Springer Verlag, 2002
17. Dudinski O, Finnin BC, Reed BL. Acceptability of thickened eye drops to human subjects. Curr Ther Res Clin Exp 1983; 33: 322-327
18. Gilbard JP, Rossi SR, Heyda KG. Tear film and ocular surface changes after closure of the meibomian gland orifices in the rabbit. Ophthalmology 1989; 96: 1180-1186
19. Goto E, Endo K, Suzuki A et al. Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2003; 44: 533-539
20. Göbbels M, Spitznas M. Corneal epithelial permeability of dry eyes before and after treatment with artificial tears. Ophthalmology 1992; 99: 873-878
21. Göbbels M, Spitznas M. Influence of artificial tears on corneal epithelium in dry-eye syndrome. Graefes Arch Clin Exp Ophthalmol 1989; 227: 139-141
22. Greiner JV, Glonek T, Korb DR et al. Meibomian gland phospholipids. Curr Eye Res 1996; 15: 371-375
23. Greiner JV, Glonek T, Korb DR et al. Phospholipids in meibomian gland secretion. Ophthalmic Res 1996; 28: 44-49
24. Guillon JP. Abnormal Lipid Layer. Observation, Differential Diagnosis, and Classification. In: Sullivan D et al (Hrsg). Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. New York: Plenum Press, 1998: 309-313
25. Heiligenhaus A, Koch JM, Kruse FE et al. Diagnostik und Differenzierung von Benetzungsstörungen. Ophthalmologe 1995; 92: 6-11
26. Heiligenhaus A, Koch JM, Kemper D et al. Therapie von Benetzungsstörungen. Klin Monatsbl Augenheilkd 1994; 204: 162-168
27. Holly FJ. The preocular tear film; a small but highly complex part of the eye. Arch Soc Esp Oftalmol 2005; 80: 65-68
28. Kaercher T, Honig D, Barth W. How the most common preservative affects the Meibomian lipid layer. Orbit 1999; 18: 89-97
29. Korb DR, Greiner JV, Glonek T. The effects of anionic and zwitterionic phospholipids on the tear film lipid layer. Adv Exp Med Biol 2002; 506 (Pt A): 495-499
30. Korb DR, Scaffidi RC, Greiner JV et al. The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms. Optom Vis Sci 2005; 82: 594-601
31. Langmuir I. Oil leises on water and tue nature of monomolekular extended films. J Chem Phys 1933; 1: 756-776
32. Lee S, Dausch S, Maierhofer G et al. Ein neues Therapiekonzept zur Behandlung des Trockenen Auges - die Verwendung von Phospholipid-Liposomen. Klin Monatsbl Augenheilkd 2004; 221: 825-836
33. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995; 21: 221-232
34. Locatcher-Khorazo D, Seegal BC. The bacterial flora of the healthy eye. In: Locatcher-Khorazo D, Seegal BC (Hrsg). Microbiology of the eye. St. Louis: CV Mosby, 1972: 13-23
35. Loewenstein A, Bolocinic S, Goldstein M et al. Application of eye drops to the medial canthus. Graefes Arch Clin Exp Ophthalmol 1994; 232: 680-682
36. Lozato PA, Pisella PJ, Baudouin C. Phase lipidique du film lacrymal: physiologie et pathologie. J Fr Ophtalmol 2001; 24: 643-658
37. MacKeen D, Roth H, Doane M. Ocular drug delivery by the lid (lower lid delivery). Invest Ophthalmol Vis Sci 1996; 37: 77
38. Mathers W. Evaporation from the ocular surface. Exp Eye Res 2004; 78: 389-394
39. Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology 1993; 100: 347-351
40. Mathers WD, Daley TE. Tear flow and evaporation in patients with and without dry eye. Ophthalmology 1996; 103: 664-669
41. Mathers WD, Lane JA. Meibominan gland lipids, evaporation, and tear film stability. Adv Exp Med Biol 1998; 438: 349-360
42. Mathers WD, Shields WJ, Sachdev MS et al. Meibomian gland morphology and tear osmolarity: changes with Accutane therapy. Cornea 1991; 10: 286-290
43. McCulley JP, Sciallis GF. Meibomian keratoconjunctivitis. Am J Ophthalmol 1977; 84: 788-793
44. McCulley JP, Shine W. A compositional based model for the tear film lipid layer. Trans Am Ophthalmol Soc 1997; 95: 79-88
45. McCulley JP, Shine WE. Eyelid disorders: the meibomian gland, blepharitis, and the contact lenses. Eye Contact Lens 2003; 29 (1 Suppl): 93-95
46. McCulley JP, Shine WE. The lipid layer: the outer surface of the ocular surface tear film. Biosci Rep 2001; 21: 407-418
47. Nagyova B, Tiffany JM. Components responsible for the surface tension of human tears. Curr Eye Res 1999; 19: 4-11
48. Norn MS. Natural fat in external eye. Vital-stained by Sudan III powder. Acta Ophthalmol (Copenh) 1980; 58: 331-336
49. Peters K, Millar TJ. The role of different phospholipids on tear break-up time using a model eye. Curr Eye Res 2002; 25: 55-60
50. Rolando M, Refojo MF, Kenyon KR. Increased tear evaporation in eyes with keratoconjunctivitis sicca. Arch Ophthalmol 1983; 101: 557-558
51. Rolando M, Refojo MF, Kenyon KR. Tear water evaporation and eye surface diseases. Ophthalmologica 1985; 190: 147-149
52. Roth HW, Koulen-Reitz G, Brunk G. Zur Langzeittherapie des Trockenen Auges mit einem Liposomenspray. Augenspiegel 2002; 48 (9): 54-58
53. Sharma A, Tiwari S, Khanna R et al. Hydrodynamics of meniscus-induced thinning of the tear film. In: Sullivan D et al ( (Hrsg). Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. New York: Plenum Press, 1998: 425-431
54. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol 1995; 113: 1266-1270
55. Shine WE, McCulley JP. Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch Ophthalmol 1998; 116: 849-852
56. Shine WE, McCulley JP. Meibomianitis: polar lipid abnormalities. Cornea 2004; 23: 781-783
57. Shine WE, McCulley JP. Polar lipids in human meibomian gland secretions. Curr Eye Res 2003; 26: 89-94
58. Smith SE. Eyedrop instillation for reluctant children. Br J Ophthalmol 1991; 75: 480-481
59. Song CH, Choi JS, Kim DK et al. Enhanced secretory group II PLA2 activity in the tears of chronic blepharitis patients. Invest Ophthalmol Vis Sci 1999; 40: 2744-2748
60. Strempel I, Roth HW. Zur Therapie des Trockenen Auges mit einem Spray. Augenspiegel 1999; 45 (11): 16-21
61. Tiffany JM. Composition and biophysical properties of the tear film: knowledge and uncertainty. Adv Exp Med Biol 1994; 350: 231-238
62. Tiffany JM. Lipid films in water conservation of biological systems. Cell Biochem Funct 1995; 13: 177-180
63. Tiffany JM. Physiological functions of the meibomian glands. Prog Retinal Res 1995; 14: 47-74
64. Tiffany JM. The Lipid Secretion of the Meibomian Glands. Adv Lipid Res 1987; 22: 1-62
65. Tiffany JM, Winter N, Bliss G. Tear film stability and tear surface tension. Curr Eye Res 1989; 8: 507-515
66. Toda I, Shinozaki N, Tsubota K. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjogren's syndrome. Cornea 1996; 15: 120-128
67. Tomlinson A, Trees GR. Effect of preservatives in artificial tear solutions on tear film evaporation. Ophthalmic Physiol Opt 1991; 11: 48-52
68. Trees GR, Tomlinson A. Effect of artificial tear solutions and saline on tear film evaporation. Optom Vis Sci 1990; 67: 886-890
69. Tsubota K, Monden Y, Yagi Y et al. New treatment of dry eye: the effect of calcium ointment through eyelid skin delivery. Br J Ophthalmol 1999; 83: 767-770
70. Wilson CG, Zhu YP, Frier M et al. Ocular contact time of a carbomer gel (GelTears) in humans. Br J Ophthalmol 1998; 82: 1131-1134
71. Zhao J, Manthorpe R, Wollmer P. Surface activity of tear fluid in patients with primary Sjogren's syndrome. Clin Physiol Funct Imaging 2002; 22: 24-27